These webcasts and presentations contain "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, future operating and financial performance, product development, regulatory approvals, market position, expenditures, impact of acquisitions and dispositions, business strategy and restructuring plans. These statements use words, and variations of words, such as "will," "plan," "expect," , "anticipate," "estimate," "next," "project," "potential," "continue," "expand" and "grow". You are cautioned not to rely on these forward-looking statements. These statements are based on current assumptions and expectations of future events at the time they are made and thus are inherently subject to uncertainty.

If underlying assumptions prove inaccurate, or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed in these forward-looking statements. Risks and uncertainties include, but are not limited to: economic and financial market factors, such as interest rate and currency exchange rate fluctuations; competition, including technological advances, new products and patents attained by competitors; challenges inherent in product development, including uncertainty of clinical success and obtaining regulatory approvals; challenges to patents; the impact of patent expirations; uncertainty of commercial success of new and existing products; significant adverse litigation or government action, including related to product liability claims; the ability of the company to successfully execute strategic plans including restructuring plans; the impact of business combinations and divestitures and the possibility that the expected benefits and opportunities of an acquisition are not realized in the anticipated time frame or at all; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; changes to applicable laws and regulations, including tax laws and global health care reforms; trends toward health care cost containment; financial instability of international economies and legal systems and sovereign risk; manufacturing difficulties or delays, internally or within the supply chain; increased scrutiny of the health care industry by government agencies; product efficacy or safety concerns resulting in product recalls or regulatory action; and the potential failure to meet obligations in compliance agreements with government bodies.

A further list and description of these risks, uncertainties and other factors can be found in the company's most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors,” and in the company's subsequent filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, on this Internet site (www.jnj.com) under “Investors—SEC Filings,” or on request from Johnson & Johnson. Information in each of these presentations is as of the dates and time periods indicated therein, and the company does not undertake to update any of the information contained in these materials. Accordingly, YOU SHOULD NOT RELY ON THE ACCURACY OF ANY OF THE STATEMENTS OR OTHER INFORMATION CONTAINED IN ANY ARCHIVED WEBCASTS OR ON DEMAND VIDEOS.

Webcasts on this website are the property of Johnson & Johnson. Any redistribution, retransmission or rebroadcast of this webcast in any form without the express written consent of Johnson & Johnson is strictly prohibited. Please see our Legal Notice for more information about the content of this website and copyright laws.

Webcasts & Presentations

Archived Events
Date Event Details
Dec 05, 2018 at 10:15 AM EST
Citi's 2018 Global Healthcare Conference
Nov 13, 2018 at 8:35 AM EST
Credit Suisse 27th Annual Healthcare Conference
Oct 16, 2018 at 8:30 AM EDT
Johnson & Johnson Third Quarter Earnings Call and Webcast
Sep 14, 2018 at 9:55 AM EDT
Morgan Stanley 16th Annual Global Healthcare Conference
Sep 13, 2018 at 10:00 AM EDT
Pharmaceutical Business Investor Call
Sep 06, 2018 at 12:45 PM EDT
Barclays Global Consumer Staples Conference
Sep 06, 2018 at 9:45 AM EDT
2018 Wells Fargo 13th Annual Healthcare Conference
Aug 27, 2018 at 8:00 AM EDT
MARINER and COMMANDER HF studies for XARELTO Webcast
Jul 17, 2018 at 8:30 AM EDT
Johnson & Johnson Second Quarter Earnings Call and Webcast
Jun 27, 2018
Health for Humanity Webcast Changing the Trajectory of Human Health
Joseph Wolk, VP, Investor Relations, Adrian Thomas, VP, Global Public Health & Access, Paulette Frank, VP, Global Environmental Health, Safety and Sustainability, Francois Sallans, Chief Quality Officer, Joanne Waldstreicher, Chief Medical Officer
Jun 12, 2018 at 9:20 AM PDT
Goldman Sachs 39th Annual Global Healthcare Conference
Jun 06, 2018 at 10:00 AM EDT
Jefferies 2018 Global Healthcare Conference
May 16, 2018
Johnson & Johnson Consumer and Medical Devices Business Review
Consumer and Medical Devices Business Review
May 16, 2018
8:40 a.m. – 2:30 p.m.


The Hyatt Regency Hotel, New Brunswick, NJ

Agenda
 
 
Topic Speaker Presentation Podcast Video
Opening Remarks Alex Gorsky, Chairman and Chief Executive Officer test test Video
Competing in a Changing World Jorge Mesquita, Executive Vice President, Worldwide Chairman, Consumer
Josh Ghaim, PhD, Global Chief Technology Officer, Consumer
Alison Lewis, Chief Marketing Officer, Consumer
test test Video
Consumer Q&A Panel     test Video
Break/Exhibits        
Competing in a Changing Environment Sandra Peterson, Executive Vice President, Group Worldwide Chair test test Video
Changing the Trajectory of Atrial Fibrillation and Stroke Shlomi Nachman, Company Group Chairman, Interventional Solutions & Specialty Surgery test test Video
Building Our Orthopaedics Business for the Future Ciro Römer, Company Group Chairman, DePuy Synthes and Medical Devices North America test test Video
Shaping the Future of Surgery Michael del Prado, Company Group Chairman, Ethicon test test Video
Innovation Peter Shen, PhD, Global Head of R&D, Medical Devices
Euan Thomson, PhD, Global Head of R&D, Medical Devices
test test Video
Lunch/Exhibits        
Leading in Eye Health Ashley McEvoy, Company Group Chairman, Vision
Xiao-Yu Song, MD, PhD, Worldwide R&D Leader, Vision
test test Video
MD Q&A Panel     test Video
Enterprise Panel/Conclusion Alex Gorsky, Chairman and Chief Executive Officer
Dominic Caruso, Executive Vice President and Chief Financial Officer
    Video
Apr 26, 2018 at 10:00 AM EDT
Johnson & Johnson 2018 Annual Meeting of Shareholders
Apr 17, 2018 at 8:30 AM EDT
Johnson & Johnson First Quarter Earnings Call and Webcast
Jan 23, 2018 at 8:30 AM EST
Johnson & Johnson Fourth Quarter Earnings Call and Webcast

Cautionary Statement                         

These webcasts and presentations contain "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, future operating and financial performance, product development, regulatory approvals, market position, expenditures, impact of acquisitions and dispositions, business strategy and restructuring plans. These statements use words, and variations of words, such as "will," "plan," "expect," , "anticipate," "estimate," "next," "project," "potential," "continue," "expand" and "grow". You are cautioned not to rely on these forward-looking statements. These statements are based on current assumptions and expectations of future events at the time they are made and thus are inherently subject to uncertainty.

If underlying assumptions prove inaccurate, or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed in these forward-looking statements. Risks and uncertainties include, but are not limited to: economic and financial market factors, such as interest rate and currency exchange rate fluctuations; competition, including technological advances, new products and patents attained by competitors; challenges inherent in product development, including uncertainty of clinical success and obtaining regulatory approvals; challenges to patents; the impact of patent expirations; uncertainty of commercial success of new and existing products; significant adverse litigation or government action, including related to product liability claims; the ability of the company to successfully execute strategic plans including restructuring plans; the impact of business combinations and divestitures and the possibility that the expected benefits and opportunities of an acquisition are not realized in the anticipated time frame or at all; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; changes to applicable laws and regulations, including tax laws and global health care reforms; trends toward health care cost containment; financial instability of international economies and legal systems and sovereign risk; manufacturing difficulties or delays, internally or within the supply chain; increased scrutiny of the health care industry by government agencies; product efficacy or safety concerns resulting in product recalls or regulatory action; and the potential failure to meet obligations in compliance agreements with government bodies.

A further list and description of these risks, uncertainties and other factors can be found in the company's most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors,” and in the company's subsequent filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, on this Internet site (www.jnj.com) under “Investors—SEC Filings,” or on request from Johnson & Johnson. Information in each of these presentations is as of the dates and time periods indicated therein, and the company does not undertake to update any of the information contained in these materials. Accordingly, YOU SHOULD NOT RELY ON THE ACCURACY OF ANY OF THE STATEMENTS OR OTHER INFORMATION CONTAINED IN ANY ARCHIVED WEBCASTS OR ON DEMAND VIDEOS.

Webcasts on this website are the property of Johnson & Johnson. Any redistribution, retransmission or rebroadcast of this webcast in any form without the express written consent of Johnson & Johnson is strictly prohibited. Please see our Legal Notice for more information about the content of this website and copyright laws.

This site uses cookies as described in our Cookie Policy Please click the "Accept" button or continue to use our site if you agree to our use of cookies.